<DOC>
	<DOCNO>NCT00953355</DOCNO>
	<brief_summary>Context : Metformin administration woman polycystic ovary syndrome ( PCOS ) improve hormonal metabolic pattern beneficial effect term reproductive outcome intermediate cardiovascular disease risk factor . Furthermore , reduce folate vitamin B12 , increase homocysteine ( Hcy ) level find type-2 diabetes mellitus patient treat metformin . Objective : To evaluate metformin administration exert effect Hcy level , folate supplementation may improve endothelial structure function PCOS patient .</brief_summary>
	<brief_title>Metformin Folate Supplementation Polycystic Ovary Syndrome ( PCOS ) Patients</brief_title>
	<detailed_description>Fifty patient affect PCOS without additional metabolic cardiovascular disease group two age- body mass index-matched treatment arm . Interventions : A six-month course metformin ( 1700 mg daily ) plus folic acid ( 400 microgram daily ) ( experimental group , n=25 ) placebo ( control group , n=25 ) supplementation . In patient evaluate : Complete hormonal metabolic pattern , serum Hcy , folate , vitamin B12 , endothelin-1 ( ET-1 ) concentration , brachial artery diameter baseline ( BAD-B ) reactive hyperemia ( BAD-RH ) , flow-mediated dilation ( FMD ) , intima-media thickness ( IMT ) common carotid artery .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Anovulation</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>PCOS age &lt; 18 &gt; 35 year BMI &gt; 35 kg/m2 neoplastic , metabolic , hepatic , renal , cardiovascular disorder Current previous use oral contraceptive , glucocorticoid , antiandrogens , ovulation induction agent , antidiabetic antiobesity drug hormonal drug .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>